| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 07/20/2006 | US20060160804 Novel pyridazine derivatives and medicines containing the same as effective ingredients |
| 07/20/2006 | US20060160803 Cinnamide and hydrocinnamide derivatives with kinase inhibitory activity |
| 07/20/2006 | US20060160801 Pyrimidinone derivaties as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes |
| 07/20/2006 | US20060160798 3-Cyclohexyl-1-methyl-2-pyridin-2-yl-1H-indole-6-carboxylic acid methyl ester; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons |
| 07/20/2006 | US20060160794 Such as [1-(3,5-bis-trifluoromethylbenzyl)-5-imidazol-1-yl-1H-[1,2,3]triazol-4-yl]-[5-(2-chlorophenyl)-3-hydroxymethyl-isoxazol-4-yl]-methanone; for treatment of depression, anxiety, irritable bowel syndrome, and emesis |
| 07/20/2006 | US20060160790 Thioureas as factor Xa inhibitors |
| 07/20/2006 | US20060160786 e.g. 5-[3-[4-(3-fluoro-2-methylphenoxy)piperidin-1-yl]-5-(methoxymethyl)-4H-1,2,4-triazol-4-yl]-2-methoxypyridine; treatment of arousal disorder, orgasmic disorder, sexual pain disorder and premature ejaculation, preterm labor, appetite and feeding disorders, dysmenorrhoea, congestive heart failure |
| 07/20/2006 | US20060160783 Novel omeprazole forms and related methods |
| 07/20/2006 | US20060159678 Modulators of cytokine mediated signaling pathways and integrin alphabeta3 receptor antagonists for combination therapy |
| 07/20/2006 | US20060156490 Symmetrical diazo compounds comprising 2-imidazolium groups and a cationic linker, compositions comprising them, method of coloring, and device |
| 07/20/2006 | US20060156489 Dyssymmetrical diazo compounds having at least one 4-pyridinium unit and a cationic or non-cationic linker, compositions comprising them, method of coloring, and device |
| 07/20/2006 | US20060156488 For the dyeing of keratin |
| 07/20/2006 | CA2594770A1 5-pyrrolidinylsulfonyl isatin derivatives |
| 07/20/2006 | CA2593482A1 Heteroaryl substituted quinolin-4-ylamine analogues |
| 07/20/2006 | CA2592723A1 4- (1h-indol-3-yl) -pyrimidin-2-ylamine derivates and their use in therapy |
| 07/20/2006 | CA2592611A1 2-(cyclic aminocarbonyl)indoline derivative and medicinal composition containing the same |
| 07/20/2006 | CA2590894A1 Preparation of crude candesartan cilexetil |
| 07/19/2006 | EP1681058A2 Pharmacologically active cns compounds |
| 07/19/2006 | EP1680415A1 Pyrrolidinyl urea derivatives as angiogenesis inhibitors |
| 07/19/2006 | EP1680406A1 N-substituted benzene sulfonamides |
| 07/19/2006 | EP1680402A1 Derivatives of n-[[phenyl(piperidine-2-yl)methyl]benzamide, preparation method thereof and applications of same in therapeutics |
| 07/19/2006 | EP1680401A2 Indolinone derivatives and their use in treating disease-states such as cancer |
| 07/19/2006 | EP1680114A2 Triazole compounds and uses related thereto |
| 07/19/2006 | EP1370556B1 Metalloproteinase inhibitors |
| 07/19/2006 | EP1301507B1 Mannich base prodrugs of 3 - (pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases |
| 07/19/2006 | EP1299361B1 Pyrazole derivatives |
| 07/19/2006 | EP1097927B1 Cyanoiminoquinoxaline derivatives |
| 07/19/2006 | CN1805957A Azetidine compounds |
| 07/19/2006 | CN1805945A Biaryl substituted thiazoles, oxazoles and imidazoles as sodium channel blockers |
| 07/19/2006 | CN1805930A Hydroxamic acids useful in the treatment of hyper-proliferative disorders |
| 07/19/2006 | CN1805929A Phosphodiesterase 4 inhibitors |
| 07/19/2006 | CN1805748A 2-aminopyrimidine derivatives as RAF kinase inhibitors |
| 07/19/2006 | CN1805742A Cis-imidazolines as MDM2 inhibitors |
| 07/19/2006 | CN1803797A Inhibitors of dipeptidyl peptidase IV |
| 07/19/2006 | CN1803796A Highly effective environment friendly triazine amino stilbene fluorescent bleachng agent |
| 07/19/2006 | CN1803784A 4-phenyl-1-piperazinyl, -piperidinyl and -tetrahydropyridyl derivatives |
| 07/19/2006 | CN1264845C 1,2,4,5-pyromellitic anhydride preparation |
| 07/19/2006 | CN1264838C Indole derivatives for treating central nervous system disease |
| 07/19/2006 | CN1264828C Nitric ester and nitrate salts of specific drugs |
| 07/19/2006 | CN1264825C Dihydro-benzo [b][1,4] diazepin-2-one derivative as mglur 2 antagonists II |
| 07/19/2006 | CN1264823C Process for preparing retroviral protease inhibitors and its intermediates |
| 07/19/2006 | CN1264574C Oral preparations |
| 07/18/2006 | USRE39198 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgesics |
| 07/18/2006 | USRE39197 diaryl sulfides, substituted with cinnamides, such as (2,4-Dichlorophenyl)[2-(E-((6-hydroxyhexylamino)carbonyl)ethenyl)phenyl]sulfide, used for treating inflammatory and immune diseases in mammals |
| 07/18/2006 | US7078529 Imidazole derivatives |
| 07/18/2006 | US7078528 Biimidazole diamide anion binding agents |
| 07/18/2006 | US7078424 Central nervous system disorders; alopecia |
| 07/18/2006 | US7078423 Nitrogen compounds used as xanthine oxidase inhibitors, for prophylaxis of inflammation, reperfusion injuries, gout or inflammatory bowel disorders |
| 07/18/2006 | US7078422 Activator for peroxisome proliferator-activated receptor |
| 07/18/2006 | US7078421 Substituted phenylacetic acids |
| 07/18/2006 | US7078419 Cytokine inhibitors |
| 07/18/2006 | US7078418 e.g., 2,6-bis(1-aziridino-1-hydroxyiminomethyl)pyridine; treating colon, stomach, lung, breast and uterus cancer |
| 07/18/2006 | US7078414 Derivatives of 3-guanidinocarbonyl-1-heteroaryl-pyrrole, preparation process and intermediates of this process, their use as medicaments, and pharmaceutical compositions comprising them |
| 07/18/2006 | US7078403 Antiviral agents |
| 07/18/2006 | CA2407416C Alkynyl phenyl heteroaromatic glucokinase activators |
| 07/18/2006 | CA2356320C Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 07/18/2006 | CA2325781C New amino pyrrolin compounds, their preparation process and the pharmaceutical compositions therein |
| 07/18/2006 | CA2242425C Quinazoline derivatives as vegf inhibitors |
| 07/13/2006 | WO2006073967A1 Piperidine derivatives as prodrugs of potassium channel inhibitors |
| 07/13/2006 | WO2006073592A2 SALTS OF N-[2-({3R)-1-[trans-4-HYDROXY-4-(6-METHOXYPYRIDIN-3-YL)-CYCLOHEXYL]PYRROLIDINE-3-YL}AMINO)-2-OXOETHYL]-3-(TRIFLUOROMETHYL)BENZAMIDE |
| 07/13/2006 | WO2006073519A1 Olmesartan medoxomil with reduced levels of impurities |
| 07/13/2006 | WO2006073518A1 Process for preparing olmesartan medoxomil at ph higher than 2.5 |
| 07/13/2006 | WO2006073376A2 Preparation of irbesartan |
| 07/13/2006 | WO2006073367A1 5-thioxo-1,5-dihydro-2h-pyrrol-2-one derivatives as liver x receptor modulators |
| 07/13/2006 | WO2006073202A1 METHOD OF TUMOR SUPPRESSION AND EVALUATION OF ANTICANCER AGENT BASED ON GSK3β INHIBITORY EFFECT |
| 07/13/2006 | WO2006073167A1 Pyrrolidine derivatives |
| 07/13/2006 | WO2006072736A1 N- (heteroaryl) -1h-indole-2-carb0xamide derivatives and their use as vanilloid trpv1 receptor ligands |
| 07/13/2006 | WO2006072426A1 Alkinyl-oxypyrimidine used in the form of pesticides |
| 07/13/2006 | WO2006072353A1 Azetidine-substituted pyrazolines as par-1 antagonists |
| 07/13/2006 | WO2006072350A1 Cyanoguanidine-substituted pyrazolines |
| 07/13/2006 | WO2006039718A3 Aryl nitrogen-containing bicyclic compounds and their use as kinase inhibitors |
| 07/13/2006 | WO2006030977A3 Imidazole derivatives as large conductance calcium-activated k channel openers |
| 07/13/2006 | WO2006021833A3 Bisbenzamidines for the treatment of pneumonia |
| 07/13/2006 | WO2006021457A3 Pyrimidine derivatives |
| 07/13/2006 | WO2006002088A3 Amino-quinazoline derivatives as antitumor agents |
| 07/13/2006 | US20060155129 etherification of 4-(6'-chloro-5'-methylpyrimidin-4'-yloxypiperidine)-1-carboxylic acid isopropyl ester with 2-Fluoro-4-methanesulfonylphenol, to form 4-[6-(2-fluoro-4-methanesulfonyl-phenoxy)-5-methyl-pyrimidin-4-yloxy]-piperidine-1-carboxylic Acid Isopropyl Ester; antidiabetic agents |
| 07/13/2006 | US20060155128 Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto |
| 07/13/2006 | US20060155078 rubber crosslinking agent which exhibits excellent storage stability and heat resistance; a compound having a thiol group protected by a maleimide compound and an active hydrogen-containing group; rubber laminate |
| 07/13/2006 | US20060155015 Aqueous emulsion of ultraviolet-absorbing resin and emulsion resin composition |
| 07/13/2006 | US20060154977 Therapeutic molecules and methods-1 |
| 07/13/2006 | US20060154967 e.g. [2-methyl-5-trifluoromethyl-2H-1,2,3-triazole-4-carboxylic acid methyl ester; fungicide; against the phytopathogenic fungi: Fungi imperfecti (Botrytis, Pyricularia, Helminthosporium), Basidiomycetes (Rhizoctonia, Hemileia), Ascomycetes classes (Venturia, Erysiphe), Oomycetes classes (Phytophthora) |
| 07/13/2006 | US20060154960 Phosphodiesterase 4 inhibitors |
| 07/13/2006 | US20060154942 Quinazolinone derivatives useful as anti-hyperalgesic agents |
| 07/13/2006 | US20060154935 Quinazolines useful as modulators of ion channels |
| 07/13/2006 | US20060154931 phosphodiesterase (PDE) inhibitors; 2-[4-(4-Pyridin-4-yl-2H-pyrazol-3-yl)-phenoxymethyl]-quinoline; for treating central nervous system disorders, neurodegenerative and psychiatric disorders |
| 07/13/2006 | US20060154928 Novel 2,4-diamino-1,3,5-triazine derivative |
| 07/13/2006 | US20060154916 Condensed azepines as vasopressin agonists |
| 07/13/2006 | US20060154897 Ophthalmic compositions for treating ocular hypertension |
| 07/13/2006 | US20060154872 chemical intermediate for Hemiasterlin, first isolated from the sponge Hemiasterella; anticarcinogenic agent for treatment of colon cancer, tumor; prevention of restenosis of blood vessels subject to traumas such as angioplasty and stenting |
| 07/13/2006 | US20060153783 Triazine derivatives as uv absorbers |
| 07/13/2006 | DE102005000747A1 Substituierte Pyrimidine Substituted pyrimidines |
| 07/13/2006 | CA2594418A1 N-(heteroaryl)-1h-indole-2-carb0xamide derivatives and their use as vanilloid trpv1 receptor ligands |
| 07/13/2006 | CA2593266A1 Aryl piperazine derivatives for the treatment of neuropsychiatric disorders |
| 07/13/2006 | CA2593044A1 Substituted oxindole derivatives, medicaments containing said derivatives and use thereof |
| 07/13/2006 | CA2592900A1 Nitrogen containing bicyclic compounds and therapeutical use thereof |
| 07/13/2006 | CA2592743A1 Disubstituted ureas as kinase inhibitors |
| 07/13/2006 | CA2592160A1 Olmesartan medoxomil with reduced levels of impurities |
| 07/13/2006 | CA2591694A1 Process for preparing olmesartan medoxomil at ph higher than 2.5 |
| 07/13/2006 | CA2590110A1 Kinase modulators and method of use |
| 07/12/2006 | EP1679312A2 Cationic symmetric 2-imidazolium diazo compounds with a cationic linking group,compositions comprising them, a dying process and kit thereof |